ATE420069T1 - Carboxamid derivate als muskarin rezeptor antagonisten - Google Patents
Carboxamid derivate als muskarin rezeptor antagonistenInfo
- Publication number
- ATE420069T1 ATE420069T1 AT06795581T AT06795581T ATE420069T1 AT E420069 T1 ATE420069 T1 AT E420069T1 AT 06795581 T AT06795581 T AT 06795581T AT 06795581 T AT06795581 T AT 06795581T AT E420069 T1 ATE420069 T1 AT E420069T1
- Authority
- AT
- Austria
- Prior art keywords
- receptor antagonists
- carboxamide derivatives
- muscarine receptor
- muscarine
- carboxamide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/12—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4409—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US71946805P | 2005-09-21 | 2005-09-21 | |
US71946705P | 2005-09-21 | 2005-09-21 | |
US71947705P | 2005-09-21 | 2005-09-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE420069T1 true ATE420069T1 (de) | 2009-01-15 |
Family
ID=37698323
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT06795581T ATE420069T1 (de) | 2005-09-21 | 2006-09-01 | Carboxamid derivate als muskarin rezeptor antagonisten |
Country Status (43)
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008002246A1 (en) * | 2006-06-28 | 2008-01-03 | Astrazeneca Ab | A pharmaceutical composition comprising an ikk2 inhibitor and a second active ingrdient. |
EP2066626B1 (de) * | 2006-09-22 | 2010-03-17 | Pfizer Limited | Azetidinderivate als antagonisten des muskarinrezeptors |
ATE512132T1 (de) * | 2007-03-16 | 2011-06-15 | Pfizer Ltd | Hydrochloridsalz von 5-ä3-(3- hydroxyphenoxy)azetidin-1-ylü-5-methyl-2,2- diphenylhexanamid |
JP5801997B2 (ja) | 2009-07-07 | 2015-10-28 | ファイザー・リミテッドPfizer Limited | 薬品の組合せを吸入するための投薬ユニット、投薬ユニットのパック、および吸入器 |
CN103201244B (zh) * | 2010-08-26 | 2015-06-17 | 阿尔比马尔公司 | 用于制备1-溴代-2-(环丙基甲氧基)-5-氟代-4-甲氧基苯的方法 |
CN103242214B (zh) * | 2013-05-02 | 2016-04-06 | 陕西步长高新制药有限公司 | 一种吲哚衍生物及其制备方法 |
KR101538846B1 (ko) * | 2013-07-30 | 2015-07-22 | 동아에스티 주식회사 | 신규한 바이페닐 유도체 및 그의 제조방법 |
EP3596046A1 (de) | 2017-03-15 | 2020-01-22 | Mylan Laboratories Ltd. | Neuartige polymorphe von (5-[3-(3-hydroxyphenoxy)azetidin-1-yl]-5-methyl-2,2-diphenylhexanamid-hydrochlorid |
PL3691620T3 (pl) | 2017-10-05 | 2022-11-21 | Fulcrum Therapeutics, Inc. | Inhibitory kinazy p38 zmniejszają poziom ekspresji genu dux4 i dalszych genów do leczenia fshd |
US10342786B2 (en) | 2017-10-05 | 2019-07-09 | Fulcrum Therapeutics, Inc. | P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD |
CN111423434A (zh) * | 2019-01-09 | 2020-07-17 | 四川海思科制药有限公司 | 一种碳酰胺衍生物及其制备方法 |
EP3990091A4 (de) * | 2019-06-25 | 2023-07-12 | Mylan Laboratories Ltd. | Verfahren und zwischenprodukte zur herstellung von hydrochloridsalz von 5-[3-(3-hydroxyphenoxy)azetidin-1-yl]-5-methyl-2,2-diphenylhexanamid |
WO2021260441A1 (en) | 2020-06-26 | 2021-12-30 | Mylan Pharma Uk Limited | Formulations including 5-[3-(3-hydroxyphenoxy)azetidin-1-yl]-5-methyl-2,2-diphenylhexanamide |
WO2023049696A1 (en) * | 2021-09-21 | 2023-03-30 | Corteva Agriscience Llc | Methylation of 2-chloro-6-fluorophenol |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2886574A (en) | 1956-11-19 | 1959-05-12 | Upjohn Co | Quaternary ammonium salts of 2, 2-diphenyl-4, 4-dimethyl-4-pyrrolidino-butyramide |
US4219559A (en) | 1979-01-10 | 1980-08-26 | Janssen Pharmaceutica N.V. | N-Heterocyclyl-4-piperidinamines |
GB8824262D0 (en) * | 1988-10-17 | 1988-11-23 | Pfizer Ltd | Therapeutic agents |
US5070087A (en) * | 1989-05-08 | 1991-12-03 | A. H. Robins Company, Incorporated | Aryl(alkyland alkylene)-N-((phenoxy and phenylthio)alkyl) aminoheterocyclics as cardiovascular, anthihistaminic, antisecretory and antiallergy agents |
US5849761A (en) | 1995-09-12 | 1998-12-15 | Regents Of The University Of California | Peripherally active anti-hyperalgesic opiates |
US6071950A (en) * | 1996-12-02 | 2000-06-06 | Kyorin Pharmaceutical Co., Ltd. | N-substituted pyrrolidine derivatives and process for preparing the same |
EP0848964B1 (de) * | 1996-12-17 | 2007-07-25 | Filtertek B.V. | Rückschlagventil, insbesondere für die Medizintechnik |
JPH11100366A (ja) * | 1997-09-29 | 1999-04-13 | Kyorin Pharmaceut Co Ltd | 新規n−置換環状アミン誘導体及びその製造法 |
US6673908B1 (en) * | 1999-02-22 | 2004-01-06 | Nuvelo, Inc. | Tumor necrosis factor receptor 2 |
GB0011838D0 (en) | 2000-05-17 | 2000-07-05 | Astrazeneca Ab | Chemical compounds |
US6667344B2 (en) * | 2001-04-17 | 2003-12-23 | Dey, L.P. | Bronchodilating compositions and methods |
CA2470956C (en) | 2001-12-20 | 2011-08-02 | Laboratorios S.A.L.V.A.T., S.A. | 1-alkyl-1-azoniabicyclo[2.2.2]octane carbamate derivatives and their use as muscarinic receptor antagonists |
MXPA03000145A (es) | 2002-01-07 | 2003-07-15 | Pfizer | Compuestos de oxo u oxi-piridina como moduladores de receptores 5-ht4. |
EP1375508A1 (de) | 2002-06-27 | 2004-01-02 | Aventis Pharma Deutschland GmbH | N6-Substituierte Adenosin Derivate und ihre Verwendung als pharmazeutische Mittel |
MXPA05002839A (es) | 2002-09-17 | 2005-05-27 | Actelion Pharmaceuticals Ltd | Derivados de 1-piridin-4-il-urea. |
-
2006
- 2006-09-01 PT PT06795581T patent/PT1928821E/pt unknown
- 2006-09-01 EA EA200800540A patent/EA013083B1/ru unknown
- 2006-09-01 KR KR1020087006784A patent/KR100976909B1/ko active IP Right Grant
- 2006-09-01 RS RS20080119A patent/RS51680B/en unknown
- 2006-09-01 BR BRPI0616111A patent/BRPI0616111B8/pt active IP Right Grant
- 2006-09-01 MX MX2008002805A patent/MX2008002805A/es active IP Right Grant
- 2006-09-01 AT AT06795581T patent/ATE420069T1/de active
- 2006-09-01 DE DE602006004768T patent/DE602006004768D1/de active Active
- 2006-09-01 EP EP06795581A patent/EP1928821B1/de active Active
- 2006-09-01 JP JP2008531819A patent/JP4221447B1/ja not_active Expired - Fee Related
- 2006-09-01 GE GEAP200610573A patent/GEP20104880B/en unknown
- 2006-09-01 WO PCT/IB2006/002727 patent/WO2007034325A1/en active Application Filing
- 2006-09-01 RS RSP-2009/0103A patent/RS50855B/sr unknown
- 2006-09-01 DK DK06795581T patent/DK1928821T3/da active
- 2006-09-01 AU AU2006293618A patent/AU2006293618B9/en active Active
- 2006-09-01 CN CN2006800348189A patent/CN101268046B/zh active Active
- 2006-09-01 PL PL06795581T patent/PL1928821T3/pl unknown
- 2006-09-01 AP AP2008004368A patent/AP1983A/xx active
- 2006-09-01 NZ NZ566023A patent/NZ566023A/en unknown
- 2006-09-01 SI SI200630186T patent/SI1928821T1/sl unknown
- 2006-09-01 ES ES06795581T patent/ES2318794T3/es active Active
- 2006-09-01 CA CA2623332A patent/CA2623332C/en active Active
- 2006-09-01 ME MEP-2009-96A patent/ME01106B/me unknown
- 2006-09-18 US US11/522,840 patent/US7772223B2/en active Active
- 2006-09-18 AR ARP060104081A patent/AR055171A1/es active IP Right Grant
- 2006-09-18 UY UY29798A patent/UY29798A1/es active IP Right Grant
- 2006-09-19 NL NL2000241A patent/NL2000241C2/nl not_active IP Right Cessation
- 2006-09-19 PE PE2006001136A patent/PE20070460A1/es active IP Right Grant
- 2006-09-20 TW TW095134738A patent/TWI322143B/zh active
- 2006-09-20 DO DO2006000202A patent/DOP2006000202A/es unknown
- 2006-09-20 GT GT200600422A patent/GT200600422A/es unknown
- 2006-09-21 HN HN2006032615A patent/HN2006032615A/es unknown
-
2008
- 2008-02-11 IL IL189453A patent/IL189453A/en active IP Right Grant
- 2008-02-12 ZA ZA200801432A patent/ZA200801432B/xx unknown
- 2008-02-25 NO NO20081001A patent/NO340975B1/no unknown
- 2008-03-12 EC EC2008008265A patent/ECSP088265A/es unknown
- 2008-03-13 CR CR9814A patent/CR9814A/es unknown
- 2008-03-19 MA MA30766A patent/MA29839B1/fr unknown
- 2008-03-19 TN TNP2008000137A patent/TNSN08137A1/fr unknown
- 2008-03-21 MY MYPI20080778A patent/MY143581A/en unknown
- 2008-11-06 HK HK08112121.9A patent/HK1117163A1/xx unknown
-
2009
- 2009-03-02 HR HR20090127T patent/HRP20090127T3/xx unknown
- 2009-03-12 CY CY20091100283T patent/CY1108880T1/el unknown
- 2009-09-09 US US12/556,285 patent/US8268881B2/en active Active
-
2010
- 2010-06-03 CU CU2010000115A patent/CU20100115A7/es active IP Right Grant
- 2010-07-01 US US12/828,732 patent/US8486992B2/en active Active
-
2013
- 2013-05-09 CR CR20130209A patent/CR20130209A/es unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE420069T1 (de) | Carboxamid derivate als muskarin rezeptor antagonisten | |
ATE394391T1 (de) | Indolderivate als histaminrezeptorantagonisten | |
ATE421511T1 (de) | Indol-3-carbonyl-spiro-piperidinderivate als antagonisten des v1a-rezeptors | |
ATE420088T1 (de) | Chinolinoncarbonsäureamidverbindungen als 5-ht4- rezeptoragonisten | |
DE602006015607D1 (de) | Thiazol-4-carboxamid-derivate als mglur5-antagonisten | |
ATE429428T1 (de) | Indanderivate als antagonisten des mch-rezeptors | |
ATE555111T1 (de) | Chinuclidinol-derivate als muscarinrezeptor- antagonisten | |
ATE505467T1 (de) | 2-aza-bicycloä3.1.0ühexanderivate als orexin- rezeptorantagonisten | |
DK1973886T3 (da) | Prokineticin-1-receptor-antagonister | |
DK1951660T3 (da) | Histamin-3-receptorantagonister | |
DK1677795T3 (da) | Muskarine acetylcholin-receptor-antagonister | |
ATE413874T1 (de) | Neue thiophen-derivate als sphingosin-1-phosphat- 1-rezeptorantagonisten | |
ATE481405T1 (de) | Thiazolpyrazolopyrimidine als antagonisten des crf1-rezeptors | |
ATE523195T1 (de) | Neue thiophen-derivate als sphingosin-1-phosphat- 1-rezeptorantagonisten | |
ATE540942T1 (de) | Imidazolderivate als ccr2-rezeptor-antagonisten | |
ATE518834T1 (de) | 2,3,4,9-tetrahydro-1h-carbazol-derivative als crth2-rezeptorantagonisten | |
ATE382034T1 (de) | Hydroisoindolin-tachykininrezeptorantagonisten | |
ATE537151T1 (de) | Pyrazolinverbindungen als mineralocorticoidrezeptorantagonisten | |
ATE485270T1 (de) | 2-phenylindole als antagonisten des prostaglandin-d2-rezeptors | |
ATE535523T1 (de) | Benzimidazolcarbonsäureamid-verbindungen als 5- ht4 rezeptor-agonisten | |
ATE462688T1 (de) | Diarylsulfone als 5-ht2a-antagonisten | |
DE602006003666D1 (de) | Indol-3-ylcarbonylpiperidinbenzimidazolderivate als v1a-rezeptorantagonisten | |
ATE477243T1 (de) | 2-aminochinoline als 5-ht(5a)- rezeptorantagonisten | |
ATE377008T1 (de) | Imidazolderivate als glutamatrezeptorantagonisten | |
DE60316411D1 (de) | Thiazolderivate als npy-rezeptorantagonisten |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1928821 Country of ref document: EP |